| Ident. | Authors (with country if any) | Title |
|---|
| 001454 |
Wolfgang H. Oertel [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Marco Zucconi [Italie] ; Heike Benes [Allemagne] ; Diego Garcia Borreguero [Espagne] ; Claudio Bassetti [Suisse] ; Markku Partinen [Finlande] ; Luigi Ferini-Strambi [Italie] ; Karin Stiasny-Kolster [Allemagne] | State of the Art in Restless Legs Syndrome Therapy : Practice Recommendations for Treating Restless Legs Syndrome |
| 001657 |
Juliane Winkelmann [Allemagne] ; Oli Polo [Finlande] ; Federica Provini [Italie] ; Sonja Nevsimalova [République tchèque] ; David Kemlink [République tchèque] ; Karel Sonka [République tchèque] ; Birgit Högl [Autriche] ; Werner Poewe [Autriche] ; Karin Stiasny-Kolster [Allemagne] ; Wolfgang Oertel [Allemagne] ; Al De Weerd [Pays-Bas] ; Luigi Ferini Strambi [Italie] ; Marco Zucconi [Italie] ; Peter P. Pramstaller [Italie] ; Isabelle Arnulf [France] ; Claudia Trenkwalder [Allemagne] ; Christine Klein [Allemagne] ; Georgios M. Hadjigeorgiou [Grèce] ; Svenja Happe [Allemagne] ; David Rye [États-Unis] ; Pasquale Montagna [Italie] | Genetics of Restless Legs Syndrome (RLS) : State-of-the-Art and Future Directions |
| 001E29 |
Felix Geser [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche] ; Ian Mckeith [Royaume-Uni] | How to diagnose dementia with lewy bodies : State of the art |
| 002330 |
Michele Tinazzi [Italie] ; Tiziana Rosso [Italie] ; Antonio Fiaschi [Italie] | Role of the somatosensory system in primary dystonia |
| 002352 |
Werner Poewe [Autriche] | Psychosis in Parkinson's disease |
| 002367 |
Andrew Kertesz [Canada] | Pick's complex and FTDP-17 |
| 002375 |
Peter Teismann [États-Unis] ; Kim Tieu [États-Unis] ; Oren Cohen [États-Unis] ; Dong-Kug Choi [États-Unis] ; DU CHU WU [États-Unis] ; Daniel Marks [États-Unis] ; Miquel Vila [États-Unis] ; Vernice Jackson-Lewis [États-Unis] ; Serge Przedborski [États-Unis] | Pathogenic role of glial cells in Parkinson's disease |
| 002386 |
Peter Brown [Royaume-Uni] | Oscillatory nature of human basal ganglia activity: Relationship to the pathophysiology of Parkinson's disease |
| 002399 |
Gregor K. Wenning [Autriche] ; Felix Geser [Autriche] ; Michaela Stampfer-Kountchev [Autriche] ; Francois Tison [Autriche] | Multiple system atrophy: An update |
| 002434 |
John Hardy [États-Unis, Royaume-Uni] | Impact of Genetic analysis on Parkinson's disease research |
| 002539 |
Georg Ebersbach [Allemagne] | An artist's view of drug-induced hallucinosis |
| 002554 |
| Deep Brain Stimulation for Movement Disorders |
| 002574 |
| Treatment of depression in idiopathic Parkinson's disease |
| 002581 |
Tamar C. Rubinstein [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | The power of cueing to circumvent dopamine deficits: A review of physical therapy treatment of gait disturbances in Parkinson's disease |
| 002592 |
Claudia Ramaker [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Anne Margarethe Stiggelbout [Pays-Bas] ; Bob Johannes Van Hilten [Pays-Bas] | Systematic evaluation of rating scales for impairment and disability in Parkinson's disease |
| 002596 |
| Surgical treatment for Parkinson's disease: Deep brain surgery |
| 002602 |
Hans-Michael Meinck [Allemagne] ; Philip D. Thompson [Australie] | Stiff man syndrome and related conditions |
| 002608 |
| Speech therapy in Parkinson's disease |
| 002627 |
Roger A. Barker [Royaume-Uni] | Repairing the brain in Parkinson's disease: Where next? |
| 002635 |
| Psychosocial counseling in Parkinson's disease |
| 002659 |
Günther Deuschl [Allemagne] ; Hagai Bergman [Israël] | Pathophysiology of nonparkinsonian tremors |
| 002661 |
Hagai Bergman [Israël] ; Günther Deuschl [Allemagne] | Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back |
| 002685 |
Igor A. Ilinsky [États-Unis] ; Kristy Kultas-Ilinsky [États-Unis] | Motor thalamic circuits in primates with emphasis on the area targeted in treatment of movement disorders |
| 002700 |
| MAO-B inhibitors for the treatment of Parkinson's disease |
| 002705 |
| Levodopa |
| 002742 |
Katrina Gwinn-Hardy [États-Unis] | Genetics of parkinsonism |
| 002748 |
J. Yelnik [France] | Functional anatomy of the basal ganglia |
| 002787 |
| Drugs to treat urinary frequency, urgency, and/or urge incontinence |
| 002788 |
| Drugs to treat gastrointestinal motility problems |
| 002789 |
| Drugs to treat dementia and psychosis |
| 002790 |
| Drugs to treat autonomic dysfunction in Parkinson's disease |
| 002804 |
Günther Deuschl [Allemagne] ; Peter Bain [Royaume-Uni] | Deep brain stimulation for trauma: Patient selection and evaluation |
| 002808 |
| DA agonists: ergot derivatives: Bromocriptine |
| 002809 |
| DA agonists: Non-Ergot derivatives: Ropinirole |
| 002810 |
| DA agonists: Non-Ergot derivatives: Pramipexole |
| 002811 |
| DA agonists: Non-Ergot derivatives: Piribedil |
| 002812 |
| DA agonists: Non-Ergot derivatives: Apomorphine |
| 002813 |
| DA agonists: Ergot derivatives: Pergolide |
| 002814 |
| DA agonists: Ergot derivatives: Lisuride |
| 002815 |
| DA agonists: Ergot derivatives: Dihydroergocryptine (DHEC) |
| 002816 |
| DA agonists: Ergot derivatives: Cabergoline |
| 002839 |
| COMT inhibitors |
| 002840 |
Dipankar Nandi [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] ; XUGUANG LIU [Royaume-Uni] ; John F. Stein [Royaume-Uni] | Brainstem motor loops in the control of movement |
| 002850 |
David J. Burn [Royaume-Uni] | Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease |
| 002859 |
| Anticholinergic therapies in the treatment of Parkinson's disease |
| 002863 |
| Amantadine and other antiglutamate agents |
| 002941 |
D. Joel [Israël] | Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease |
| 002950 |
Georg Becker [Allemagne] ; Daniela Berg [Allemagne] | Neuroimaging in basal ganglia disorders : Perspectives for Transcranial ultrasound |
| 002B01 |
T. Klockgether [Allemagne] ; U. Wüllner [Allemagne] ; A. Spauschus [Royaume-Uni] ; B. Evert [Allemagne] | The molecular biology of the autosomal-dominant cerebellar ataxias |
| 002B07 |
S. Frucht [États-Unis] ; S. Fahn [États-Unis] | The clinical spectrum of posthypoxic myoclonus |
| 002C28 |
Harvey S. Singer [États-Unis] | Current issues in tourette syndrome |
| 002C61 |
B. Q. Nguyen [États-Unis] ; A. G. Kanthasamy [États-Unis] ; D. D. Truong [États-Unis] | Animal models of myoclonus : An overview |
| 002C62 |
A. G. Kanthasamy [États-Unis] ; B. Q. Nguyen ; D. D. Truong | Animal model of posthypoxic myoclonus : II. Neurochemical, pathologic, and pharmacologic characterization |
| 002C97 |
J. L. Montastruc [France] ; Olivier Rascol [France] ; J.-M. Senard [France] | Treatment of Parkinson's disease should begin with a dopamine agonist |
| 002D35 |
J. M. Brotchie [Royaume-Uni] ; S. H. Fox [Royaume-Uni] | Quantitative assessment of dyskinesias in subhuman primates |
| 002D72 |
Pierre Pollak [France] | Neurosurgical treatment of dyskinesias : Pathophysiological consideration |
| 002D73 |
H. R. Morris [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; N. W. Wood [Royaume-Uni] | Neurofibrillary tangle Parkinsonian disorders : Tau pathology and Tau genetics |
| 002E33 |
Y. Furukawa [Canada] ; S. J. Kish [Canada] | Dopa-responsive dystonia : Recent advances and remaining issues to be addressed |
| 002E52 |
O. Lindvall [Suède] | Cerebral implantation in movement disorders : State of the art |
| 002E68 |
H. Wilms [Allemagne] ; J. Sievers [Allemagne] ; G. Deuschl [Allemagne] | Animal models of tremor |
| 002E76 |
M. W. Hayes [Australie] ; S. Graham [Australie] ; P. Heldorf [Australie] ; G. De Moore [Australie] ; J. G. L. Morris [Australie] | A video review of the diagnosis of psychogenic gait : Appendix and commentary |
| 002E77 |
J. I. Hoff [Pays-Bas] ; B. J. Van Hilten [Pays-Bas] ; R. A. C. Roos [Pays-Bas] | A review of the assessment of dyskinesias |
| 002F61 |
A. G. Riedl [Royaume-Uni] ; P. M. Watts [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | P450 enzymes and Parkinson's disease : The story so far |
| 003006 |
O. Bandmann [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. W. Wood [Royaume-Uni] | Genetic aspects of Parkinson's disease |
| 003017 |
C. Klein [Allemagne] ; P. Vieregge [Allemagne] | Fahr's disease : Far from a disease |
| 003095 |
P. A. Lapchak [États-Unis] | A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease |
| 003126 |
S. A. Factor [États-Unis] ; J. H. Friedman [États-Unis] | The emerging role of clozapine in the treatment of movement disorders |
| 003130 |
M. Jaber [États-Unis] ; S. Jones ; B. Giros ; M. G. Caron | The dopamine transporter : A crucial component regulating dopamine transmission |
| 003192 |
C. E. Clarke [Royaume-Uni] ; C. Sampaio [Portugal] | Movement disorders cochrane collaborative review group |
| 003269 |
B. Wild [Allemagne, États-Unis] ; D. M. Corcos [États-Unis] | Cerebellar hypermetria: Reduction in the early component of the antagonist electromyogram |
| 003281 |
S. Chouinard [États-Unis] ; E. D. Louis [États-Unis] ; S. Fahn [États-Unis] | Agreement among movement disorder specialists on the clinical diagnosis of essential tremor |
| 003301 |
| |
| 003302 |
| Cortical-basal ganglionic degeneration (CBGD) and its relationship to other asymmetrical cortical degeneration syndromes (ACDs) |
| 003425 |
| |
| 003490 |
Joseph Jankovic [États-Unis] | International classification of diseases, tenth revision : neurological adaptation (ICD-10 NA) : extrapyramidal and movement disorders |
| 003572 |
V. M. S. De Bruin [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases |
| 003621 |
A. H. V. Schapira [Royaume-Uni] | Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal |
| 003736 |
P. G. Strange [Royaume-Uni] | Dopamine receptors in the basal ganglia: relevance to Parkinson's disease |
| 003832 |
A. Nieoullon [France] ; KERKERIAN-LE GOFF | Cellular interactions in the striatum involving neuronal systems using classical' neurotransmitters: possible functional implications |
| 003890 |
R. Faber [États-Unis] ; M. R. Trimble | Electroconvulsive therapy in Parkinson's disease and other movement disorders |
| 003972 |
A. R. Crossman | A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment |
| 003A23 |
J. M. Walshe | Wilson's disease: yesterday, today, and tomorrow |
| 003A26 |
S. A. Factor ; J. Sanchez-Ramos ; W. J. Weiner | Trauma as an etiology of Parkinsonism: a historical review of the concept |
